Biodesix | 8-K: Current report
Biodesix | 8-K: Biodesix Announces Second Quarter 2024 Results and Highlights
Biodesix | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Biodesix | 8-K: Current report
Biodesix | 8-K: Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
Biodesix | DEFA14A: Others
Biodesix | DEF 14A: Definitive information statements
Biodesix | S-1: General form for registration of securities under the Securities Act of 1933
Biodesix | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Biodesix | 8-K: Current report
Biodesix | 8-K: Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
Biodesix | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Biodesix | 8-K: Current report
Biodesix | 8-K: Biodesix Announces Third Quarter 2023 Results and Highlights
Biodesix | 8-K: Biodesix Announces Second Quarter 2023 Results and Highlights
Biodesix | 8-K: Current report
Biodesix | 8-K: Current report
Biodesix | 8-K: Current report
Biodesix | 8-K: Biodesix Announces First Quarter 2023 Results and Highlights
Biodesix | DEFA14A: Others
No Data